期刊
EPIGENOMICS
卷 6, 期 2, 页码 215-228出版社
FUTURE MEDICINE LTD
DOI: 10.2217/epi.14.12
关键词
bromodomain inhibitor; chromatin; DNA methyltransferase inhibitor; histone deacetylase inhibitor; histone demethylase inhibitor; histone methyltransferase inhibitor; multiple myeloma
资金
- Myeloma UK
- Cancer Research UK [12103] Funding Source: researchfish
Despite recent advances in therapy, subgroups of multiple myeloma continue to have a poor prognosis. Numerous epigenetic changes have been described and occur as both etiologic and secondary events, making myeloma a good disease in which to understand the role of epigenetic therapies. Here, we describe a number of current and potential epigenetic targets in myeloma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据